Published in Acta Chir Scand Suppl on January 01, 1985
Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stage. Indian J Orthop (2011) 1.65
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res (2011) 1.10
Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J Orthop Surg Res (2012) 1.05
Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial. BMC Musculoskelet Disord (2012) 1.01
Comment on "Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stage". Indian J Orthop (2011) 0.91
Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop (2003) 0.89
Intra-articular injection of tranexamic acid reduce blood loss in cemented total knee arthroplasty. Eur J Orthop Surg Traumatol (2015) 0.89
Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clin Orthop Relat Res (2011) 0.87
The Use of Epoetin-α in Revision Knee Arthroplasty. Adv Orthop (2012) 0.82
Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid. Int Orthop (2016) 0.81
Tranexamic acid reduces blood loss and need of blood transfusion in total knee arthroplasty: A prospective, randomized, double-blind study in Indian population. Asian J Transfus Sci (2015) 0.75
Should We Use Preoperative Epoetin-α in the Mildly Anemic Patient Undergoing Simultaneous Total Knee Arthroplasty? Open Orthop J (2013) 0.75
Retracted DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med (2001) 2.80
Heterogeneity of mitotic activity in breast cancer. Histopathology (1996) 2.77
Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy. Br J Obstet Gynaecol (1999) 1.72
Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. Thromb Res (1988) 1.54
Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg (1995) 1.52
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ (1990) 1.50
Angiogenesis in invasive breast carcinoma--a prospective study of tumour heterogeneity. Eur J Cancer (2002) 1.46
Changing aneurysmal morphology after endovascular grafting: relation to leakage or persistent perfusion. J Endovasc Surg (1997) 1.45
Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit? J Intern Med (1994) 1.41
Are self-expanding stents superior to balloon-expanded in dilating aortas? An experimental study in pigs. Eur J Vasc Endovasc Surg (1996) 1.40
Combined angioplasty with the Kensey catheter and balloon angioplasty in occlusive arterial disease. A preliminary report. Acta Radiol (1992) 1.39
Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol (1994) 1.38
Adhesions: pathogenesis and prevention-panel discussion and summary. Eur J Surg Suppl (1997) 1.33
Fibrinolysis in human peritoneum during operation. Surgery (1996) 1.22
DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol (2005) 1.21
Adhesions: prevention and complications in general surgery. Eur J Surg (1997) 1.18
Flotillins as regulators of ErbB2 levels in breast cancer. Oncogene (2012) 1.18
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism (1990) 1.12
The vaginal epithelium in the postmenopause--cytology, histology and pH as methods of assessment. Maturitas (1995) 1.06
Endovascular stent-graft exclusion of an aortobronchial fistula. J Vasc Interv Radiol (1996) 1.05
Adenoid cystic carcinoma of Bartholin's gland: a report of five new cases treated with surgery and radiotherapy. Gynecol Oncol (1989) 1.02
The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol (2001) 1.01
Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Virchows Arch (1999) 1.01
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol (2000) 1.00
The effects of orchiectomy, oestrogens and cyproterone-acetate on the antithrombin-III concentration in carcinoma of the prostate. Urol Res (1981) 1.00
Cost of bowel obstruction resulting from adhesions. Eur J Surg (1997) 0.98
Depression of peritoneal fibrinolysis during operation is a local response to trauma. Surgery (1998) 0.97
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. Am J Clin Pathol (2001) 0.97
Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Histopathology (2003) 0.96
Tissue markers as predictors of postoperative adhesions. Br J Surg (1998) 0.96
Plasminogen activators and inhibitors in peritoneal tissue. APMIS (1997) 0.94
A colour Doppler ultrasound study of venous reflux in patients with chronic leg ulcers. Eur J Vasc Endovasc Surg (2001) 0.94
Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas. Virchows Arch (2001) 0.94
Quality of life associated with varying degrees of chronic lower limb ischaemia: comparison with a healthy sample. Eur J Vasc Endovasc Surg (1999) 0.94
Early activation of humoral proteolytic systems in patients with multiple trauma. Crit Care Med (1986) 0.94
The impact of starch-powdered gloves on the formation of adhesions in rats. Eur J Surg (1994) 0.93
Effects of prophylactic antibiotics in vascular surgery. A prospective, randomized, double-blind study. Ann Surg (1984) 0.92
Fibrinolysis and tourniquet. Lancet (1977) 0.92
Residual carcinoma after intracavitary irradiation of endometrial carcinoma, stage I. A study of whole-organ sections. Acta Obstet Gynecol Scand (1982) 0.92
Nottingham Health Profile and Short-Form 36 Health Survey questionnaires in patients with chronic lower limb ischemia: before and after revascularization. J Vasc Surg (2002) 0.91
Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost (1989) 0.91
Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients. Thromb Res (1991) 0.90
Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg (1986) 0.90
Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol (1999) 0.90
Postoperative fever, bowel ischaemia and cytokine response to abdominal aortic aneurysm repair--a comparison between endovascular and open surgery. Eur J Vasc Endovasc Surg (1998) 0.89
Multiblock: an aid in diagnostic immunohistochemistry. J Clin Pathol (1988) 0.88
Clinical experience with a bifurcated endovascular graft for abdominal aortic aneurysm repair. J Vasc Surg (1996) 0.88
Role of fibrinolysis in the formation of postoperative adhesions. Wound Repair Regen (1994) 0.88
Familial clustering of malignant mesothelioma. Cancer (1980) 0.88
Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest (1998) 0.87
The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia. Eur J Vasc Endovasc Surg (2000) 0.87
Colour Doppler ultrasound in diagnosing venous insufficiency. A comparison to descending phlebography. Eur J Vasc Endovasc Surg (1995) 0.87
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications. Clin Exp Metastasis (2000) 0.86
Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg (1993) 0.86
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels. Eur J Cancer (2001) 0.86
Aneurysm pressure following endovascular exclusion. Eur J Vasc Endovasc Surg (1997) 0.86
DNA measurement--an objective predictor of response to irradiation? A review of 24 squamous cell carcinomas of the oral cavity. Br J Cancer (1986) 0.85
Effect of tranexamic acid on pulmonary tissue fibrinolysis in the rat. Microvasc Res (1976) 0.85
Increased lymphatic elimination of interstitial hyaluronan during E. coli sepsis in sheep. Am J Physiol (1989) 0.85
Seeding of ePTFE carotid interposition grafts in sheep and dogs: species-dependent results. Surgery (1988) 0.85
A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers. Thromb Haemost (1995) 0.84
Comparison of oxidative metabolism in vitro in endothelial cells from different species and vessels. J Cell Physiol (1987) 0.84
Effect of increased hydrostatic pressure on lymphatic elimination of hyaluronan from sheep lung. J Appl Physiol (1985) (1988) 0.83
Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator. Gynecol Oncol (1989) 0.83
Topography of the reconstructed pelvic peritoneum after proctocolectomy. Dis Colon Rectum (1974) 0.83
Origin of carcinoma in secretory endometrium--a study using a whole-organ sectioning technique. Gynecol Oncol (1983) 0.83
Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome. Am J Surg Pathol (2001) 0.83
p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy. Eur Urol (1995) 0.83
Effects of hyperbaric oxygen treatment on neutrophil activation and pulmonary sequestration in intestinal ischemia-reperfusion in rats. Eur Surg Res (1999) 0.82
Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg (1988) 0.82
Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation. Scand J Clin Lab Invest (2001) 0.81
Reduction of gastric haemorrhage by fibrinolysis inhibition - an experimental study in rats. Thromb Haemost (1983) 0.81
Transfemoral insertion of a bifurcated endovascular graft for aortic aneurysm repair: the first 22 patients. Cardiovasc Surg (1995) 0.81
Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells. Thromb Res (1995) 0.81
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Clin Cancer Res (2001) 0.81
Prognostic importance of the nuclear proteins p53 and Rb in conjunction with DNA, nuclear morphometry and grading in endometrial carcinoma. Int J Gynecol Cancer (1997) 0.81
Effects of estrogen, orchidectomy, and cyproterone acetate on tissue fibrinolysis in patients with carcinoma of the prostate. Invest Urol (1981) 0.81
Preoperative irradiation in oral cavity carcinoma. A study with special reference to DNA pattern, histological response and prognosis. Acta Oncol (1987) 0.81
The cellular uptake of 5-hydroxytryptamine in the rat lung in vivo--a histochemical study. Acta Physiol Scand (1982) 0.81
The kinase insert domain-containing receptor (KDR) is regulated by shear stress. Scand Cardiovasc J (2002) 0.80
Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin. J Bone Joint Surg Am (1991) 0.80
Effect of shear stress on the expression of coagulation and fibrinolytic factors in both smooth muscle and endothelial cells in a co-culture model. Eur Surg Res (2008) 0.80
Paraganglioma involving the larynx. ORL J Otorhinolaryngol Relat Spec (1984) 0.80
The reciprocal translocation t(9;16)(q22;p13) is a primary chromosome abnormality in basal cell carcinomas. Cancer Res (1997) 0.80
Endometrial effects of transdermal estradiol/norethisterone acetate. Maturitas (1992) 0.79
Late aortic arch perforation by graft-anchoring stent: complication of endovascular thoracic aneurysm exclusion. J Endovasc Surg (1998) 0.79
Urokinase plasminogen activator colocalizes with CD25+ cells in atherosclerotic vessels. J Vasc Res (1998) 0.79
Experimental models for quantitative studies on adhesion formation in rats and rabbits. Eur Surg Res (1994) 0.79
Local fibrinolytic activity and its structural basis in experimental gastric ulcers. Eur J Clin Invest (1983) 0.79
The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas. Histol Histopathol (2004) 0.79
Fibrinolysis in grafted arteries and veins. Thromb Haemost (1979) 0.79
Immunohistochemical localization of plasminogen activators in human saphenous veins. Thromb Res (1986) 0.79
Vascular trauma. Review of 10 years' experience. Acta Chir Scand (1980) 0.79
Thrombosis after hip replacement. Relationship to the fibrinolytic system. Acta Orthop Scand (1989) 0.79
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications. Gynecol Oncol (2001) 0.79
Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction. Diagn Mol Pathol (1999) 0.79
Fibrinolytic activity in human legs in tourniquet ischemia. Thromb Res (1977) 0.79
Abdominal aortic aneurysms: experience with the Ivancev-Malmö endovascular system for aortomonoiliac stent-grafts. J Endovasc Surg (1997) 0.78
Effect of venous stasis on vessel wall fibrinolysis. Thromb Haemost (1984) 0.78